Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Mol Cell. 2010 Jul 9;39(1):8-24. doi: 10.1016/j.molcel.2010.06.017.

    The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.

    Source

    Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.

    Abstract

    The abundant nuclear enzyme PARP-1, a multifunctional regulator of chromatin structure, transcription, and genomic integrity, plays key roles in a wide variety of processes in the nucleus. Recent studies have begun to connect the molecular functions of PARP-1 to specific physiological and pathological outcomes, many of which can be altered by an expanding array of chemical inhibitors of PARP enzymatic activity.

    2010 Elsevier Inc. All rights reserved.

    PMID:
    20603072
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2923840
    Free PMC Article

    Images from this publication.See all images (8)Free text

    Figure 1
    Figure 3
    Figure 5
    Figure 7
    Figure 2
    Figure 4
    Figure 6
    Figure 8

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk